Geode Capital Management, LLC Impel Pharmaceuticals Inc Transaction History

Geode Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.31 - $1.75 $5,349 - $30,201	17,258 Added 11.14%	172,218 $74,000
Q2 2023 Aug 11, 2023	BUY	$1.08 - $2.75 $615 - $1,567	570 Added 0.37%	154,960 $196,000
Q1 2023 May 15, 2023	BUY	$0.96 - $4.1 $145 - $623	152 Added 0.1%	154,390 $216,000
Q4 2022 Feb 13, 2023	BUY	$2.59 - $4.0 $14,483 - $22,368	5,592 Added 3.76%	154,238 $578,000
Q3 2022 Nov 14, 2022	BUY	$5.78 - $9.32 $193,404 - $311,856	33,461 Added 29.05%	148,646 $723,000
Q2 2022 Aug 12, 2022	SELL	$5.83 - $10.12 $271,701 - $471,632	-46,604 Reduced 28.81%	115,185 $1.07 Million
Q1 2022 May 13, 2022	BUY	$5.86 - $9.85 $193,315 - $324,941	32,989 Added 25.61%	161,789 $1.03 Million
Q4 2021 Feb 11, 2022	BUY	$8.33 - $12.14 $90,663 - $132,131	10,884 Added 9.23%	128,800 $1.11 Million
Q3 2021 Nov 12, 2021	BUY	$8.38 - $26.13 $561,242 - $1.75 Million	66,974 Added 131.47%	117,916 $1.44 Million
Q2 2021 Aug 13, 2021	BUY	$7.33 - $15.2 $373,404 - $774,318	50,942 New	50,942 $450,000

14.4K

Ticker IMPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,738,800
Market Cap $475K
Description
Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The c...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.